Broadcast Retirement Network's Jeffrey Snyder discusses the state of investment in the life sciences with scientist and ...

Ahead of the J.P. Morgan Healthcare Conference, biotech leaders and analysts say companies are better equipped for the new ...

Imagine the perfect drink — a cocktail, coffee, or kombucha, perhaps. Whatever the concoction, it came together iteratively — one taste test, one tweak at a time. In much the same way, mixing ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. PALO ALTO, Calif. — At an annual meeting usually focused on the industry’s future, ...

Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once ...

Gilead Sciences is drawing up $20 million cash to partner with Cartography Biosciences and navigate drug discovery for triple-negative breast cancer and adenocarcinoma, a common form of non-small cell ...

Attend to gain insights into stalled lab leasing, slowed VC and grant funding, high lab buildout costs, and the two tier ...

In this episode, we’ll explore the nascent fields of space data and synthetic biology and identify key strategies for enterprises looking to benefit from recent advancements in science and technology.

Israel is positioned directly inside this convergence. The Israel Innovation Authority reports that roughly 1,800 health-tech and life science companies operate in the country. The national health ...

GSK alum Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy. Ellen Horste’s job is a little bit like packing for ...